← Back to all trials
Completed
NCT07662564
Thermotherapy for Reducing Pain During Arteriovenous Fistula Cannulation
Conditions: Dialysis, Pain
Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 51
Sponsor: Istanbul University
Location: Nurten Özen Fatih İ̇stanbul
Summary
Arteriovenous fistula (AVF) cannulation is a routine procedure for people receiving haemodialysis and is frequently associated with pain. Thermotherapy has been reported as an effective non-pharmacological intervention for reducing AVF cannulation-related pain; however, the optimal application duration remains unclear.
Eligibility Criteria
Inclusion Criteria:
* Patients aged 18 years and older
* Patients who received hemodialysis (HD) treatment with an arteriovenous fistula (AVF) for at least 3 months
* Patients receiving HD treatment 3 days a week for 4 hours each session
* Patients with a pain score of ⩾1 during AVF cannulation, measured by a visual analog scale (VAS)
* Patients able to communicate in Turkish
* Patients without psychiatric disorders that impair communication
* Patients who agreed to participate in the study
Exclusion Criteria:
* Patients who were known to present difficulties with fistula cannulation (requiring multiple cannulations)
* Patients with a history of hematoma or stenosis in the arteriovenous fistula (AVF)
* Patients with an infection at the fistula site
* Patients who took painkillers within 3 hours prior to treatment
* Hypersensitivity reactions and circulatory disorders due to thermotherapy
* Sensory or cognitive impairment preventing a proper assessment of pain
* Patients who did not wish to participate in the study
Source: ClinicalTrials.gov (NCT07662564). StuddyBuddy aggregates publicly available trial information.